Peter Ruf Selected Research

Trastuzumab (Herceptin)

5/2009

The trifunctional antibody ertumaxomab destroys tumor cells that express low levels of human epidermal growth factor receptor 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Ruf Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 02/2004
7	Melanoma (Melanoma, Malignant) 01/2017 - 02/2004
3	Ascites 01/2012 - 05/2010
2	Neuroblastoma 01/2022 - 01/2021
2	Carcinoma (Carcinomatosis) 01/2012 - 05/2010
1	Non-Muscle Invasive Bladder Neoplasms 09/2021
1	Ovarian Neoplasms (Ovarian Cancer) 12/2015
1	Disease Progression 12/2015
1	Lymphoma (Lymphomas) 05/2010
1	Breast Neoplasms (Breast Cancer) 05/2009
1	Residual Neoplasm 08/2008
1	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2008

Drug/Important Bio-Agent (IBA)

7	AntibodiesIBA 01/2022 - 02/2004
7	catumaxomabIBA 10/2021 - 05/2010
7	Bispecific AntibodiesIBA 01/2017 - 09/2008
6	AntigensIBA 01/2022 - 02/2004
6	Epithelial Cell Adhesion MoleculeIBA 10/2021 - 08/2008
5	Immunoglobulin G (IgG)IBA 01/2022 - 05/2010
3	CytokinesIBA 01/2021 - 02/2004
3	Immunoglobulin Fc FragmentsIBA 01/2021 - 08/2012
3	GangliosidesIBA 11/2012 - 02/2004
2	dinutuximabIBA 01/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2017
2	GD2 gangliosideIBA 08/2015 - 08/2012
2	ertumaxomabIBA 05/2010 - 05/2009
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	Cytostatic AgentsIBA 09/2021
1	Surface Antigens (Surface Antigen)IBA 01/2021
1	IpilimumabIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 12/2015
1	9-O-acetyl-GD3 gangliosideIBA 11/2012
1	InterferonsIBA 08/2012
1	Peptides (Polypeptides)IBA 08/2012
1	Immunoglobulins (Immunoglobulin)IBA 01/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012
1	Hepatitis B e AntigensIBA 05/2010
1	human ERBB2 proteinIBA 05/2009
1	Trastuzumab (Herceptin)FDA Link 05/2009
1	InterleukinsIBA 08/2008
1	PerforinIBA 02/2004
1	Proteoglycans (Proteoglycan)IBA 02/2004

Therapy/Procedure

8	Therapeutics 01/2022 - 02/2004
3	Immunotherapy 08/2015 - 08/2012
1	Intravesical Administration 09/2021
1	Intravenous Administration 08/2015
1	Aftercare (After-Treatment) 01/2012